Under the direction of Drs. Fred Gordin (DC VAMC), Lawrence D'Angelo (CNMC), and Mary Young (GU), the primary goal ofthe DC D-CFAR CLINICAL CORE C is to expand and strengthen existing collaborations between 5 academic medical centers and 2 major community providers of HIV/AIDS care in DC in order to encourage and support new investigators ~ women, minorities, and early- and mid-career scientists ~ to embark on innovative, multidisciplinary, and multiinstitutional clinical and translational research initiatives and to provide them the tools and support needed at multiple levels to be successful in competing for their own federal research awards. The ultimate aim ofthe DC D-CFAR is to address the urgent public health and research needs of impoverished populations in this high prevalence area and to seek new ways to intervene and bridge research gaps from bench to bedside to the community. Clinical Core C brings generous institutional support for the efforts of experienced research investigators to make an impact on the DC epidemic. Core C activities will also be supported through direct CFAR support, charge-backs to Core C users as appropriate, and other options. Core C enhances and adds value to the clinical and translational research activities of DC D-CFAR investigators through the following four Specific Aims: 1. To promote multidisciplinary clinical and translational HIV/AIDS research at seven collaborating clinical sites; 2. To mentor and train new investigators, especially women and minorities, in the design and implementation of innovative multidisciplinary clinical and translational HIV/AIDS research projects supported through the DC D-CFAR Developmental Core B; 3. To promote use by investigators of the DC D-CFAR Repository and Database and other local repository and database resources; 4. To provide outreach and education to DC D-CFAR key stakeholders - the HIV/AIDS community, patients, investigators, and staff at collaborating sites- about DC D-CFAR clinical research opportunities, developments, and outcomes.
Participating sites: (1) Children's National Medical Center (CNMC);(2) George Washington University Medical Center (GW);(3) Georgetown University Hospital (GU);(4) Howard University Hospital (HU);(5) DC Veterans Affairs Medical Center (DC VAMC);(6) Unity Health Care, Inc. (UNITY);(7) Whitman-Walker Clinic (WWC), all in the District of Columbia, where adult prevalence of HIV infection is estimated at 3%, and even higher in certain sub-groups.
|Calabrese, Sarah K; Magnus, Manya; Mayer, Kenneth H et al. (2017) ""Support Your Client at the Space That They're in"": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation. AIDS Patient Care STDS 31:196-204|
|Farmer, Shu; Mindry, Deborah; Comulada, W Scott et al. (2017) Mobile Phone Ecological Momentary Assessment of Daily Stressors Among People Living With HIV: Elucidating Factors Underlying Health-Related Challenges in Daily Routines. J Assoc Nurses AIDS Care 28:737-751|
|Latkin, Carl A; Van Tieu, Hong; Fields, Sheldon et al. (2017) Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav 21:1163-1170|
|Rosenberg, Alana; Groves, Allison K; Blankenship, Kim M (2017) Comparing Black and White Drug Offenders: Implications for Racial Disparities in Criminal Justice and Reentry Policy and Programming. J Drug Issues 47:132-142|
|Pollack, Ross A; Jones, R Brad; Pertea, Mihaela et al. (2017) Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe 21:494-506.e4|
|Paquin-Proulx, D; Ching, C; Vujkovic-Cvijin, I et al. (2017) Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection. Mucosal Immunol 10:69-78|
|Xia, Jie; Feng, Bo; Shao, Qianhang et al. (2017) Virtual Screening against Phosphoglycerate Kinase 1 in Quest of Novel Apoptosis Inhibitors. Molecules 22:|
|Castel, Amanda D; Kuo, Irene; Mikre, Meriam et al. (2017) Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing. J Acquir Immune Defic Syndr 74 Suppl 2:S96-S103|
|Raposo, Rui André Saraiva; de Mulder Rougvie, Miguel; Paquin-Proulx, Dominic et al. (2017) IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight 2:e85811|
|Xia, Jie; Hsieh, Jui-Hua; Hu, Huabin et al. (2017) The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening. J Chem Inf Model 57:1414-1425|
Showing the most recent 10 out of 160 publications